@dr.amybkillen's erectile dysfunction advice, fact-checked
Quick answer
Erectile dysfunction affects 30 million American men and often indicates underlying cardiovascular disease. Treatment approaches include lifestyle modification, hormone replacement for confirmed hypogonadism (testosterone <300 ng/dL), and emerging therapies like low-intensity shockwave treatment, though evidence quality varies significantly between interventions.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What does this video actually claim?
Dr. Amy B Killen offers four strategies for erectile dysfunction: healthy lifestyle choices (comparing cardiovascular health to erectile function), low-intensity shockwave therapy requiring 6+ sessions, testosterone optimization to the mid-upper reference range, and vacuum pumps. She emphasizes medical supervision for shockwave devices like Softwave.
The video cuts off mid-sentence about vacuum pumps, but her core message is clear: ED treatment should combine lifestyle changes with medical interventions.
Does shockwave therapy actually work for ED?
The evidence is mixed, which Killen doesn't mention. A 2019 systematic review by Clavijo et al. in Sexual Medicine found modest improvements in erectile function scores, but many studies were small and short-term. The International Index of Erectile Function improved by 2-5 points on average.
More concerning, a 2021 meta-analysis by Angulo et al. in the Journal of Sexual Medicine found significant heterogeneity between studies. Some showed benefits, others showed none. The FDA hasn't approved any shockwave devices specifically for ED treatment.
Killen's recommendation for 6+ sessions matches most protocols, but she oversells the certainty of benefits.
Is the testosterone advice sound?
This is where Killen gets it mostly right. Multiple studies show testosterone therapy can improve erectile function in men with confirmed hypogonadism. The 2018 TRAVERSE safety study found men with testosterone levels below 300 ng/dL benefited most from replacement therapy.
Her advice to target the "mid-upper" reference range makes clinical sense. Most labs use 300-1000 ng/dL as normal, and men with levels around 600-800 ng/dL typically report better sexual function than those at 300-400 ng/dL.
However, she doesn't mention the cardiovascular risks. The TRAVERSE trial also showed increased risk of major adverse cardiac events in some men over 65.
What about the lifestyle claims?
Killen nails this one. The connection between cardiovascular health and erectile function is well-established. The Massachusetts Male Aging Study found men with heart disease had 39% higher risk of developing ED over nine years.
A 2018 study by Maiorino et al. in Journal of Sexual Medicine showed Mediterranean diet improved erectile function scores by 4.2 points over two years. Regular exercise produced similar benefits in multiple trials.
The "what's good for your heart" advice isn't just folksy wisdom. It's backed by solid data showing shared vascular mechanisms.
What's the bottom line on this advice?
Killen gets the fundamentals right but oversells some treatments. Lifestyle changes and testosterone therapy (for hypogonadal men) have strong evidence. Shockwave therapy is more experimental than she suggests.
Her emphasis on medical supervision is appropriate. ED often signals underlying cardiovascular disease, so proper evaluation matters more than any single treatment. The video would be stronger if she mentioned this diagnostic angle instead of jumping straight to interventions.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @dr.amybkillen's erectile dysfunction advice, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@dr.amybkillen's erectile dysfunction advice, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Erectile dysfunction affects 30 million American men and often indicates underlying cardiovascular disease.
FormBlends verdict
Erectile dysfunction affects 30 million American men and often indicates underlying cardiovascular disease. Treatment approaches include lifestyle modification, hormone replacement for confirmed hypogonadism (testosterone <300 ng/dL), and emerging therapies like low-intensity shockwave treatment, though evidence quality varies significantly between interventions.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Erectile dysfunction affects 30 million American men and often indicates underlying cardiovascular disease. Treatment approaches include lifestyle modification, hormone replacement for confirmed hypogonadism (testosterone <300 ng/dL), and emerging therapies like low-intensity shockwave treatment, though evidence quality varies significantly between interventions.
- Mediterranean diet improved erectile function scores by 4.2 points over two years in randomized trials
- Testosterone therapy benefits men with confirmed hypogonadism (levels below 300 ng/dL) but carries cardiovascular risks
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Mediterranean diet improved erectile function scores by 4.2 points over two years in randomized trials
- Testosterone therapy benefits men with confirmed hypogonadism (levels below 300 ng/dL) but carries cardiovascular risks
- Shockwave therapy for ED lacks FDA approval and shows inconsistent results across studies
- Vacuum erection devices achieve satisfactory results in 60-80% of men when properly used
- ED often indicates underlying heart disease and requires proper medical evaluation
- The connection between cardiovascular health and erectile function is supported by large longitudinal studies
- Most shockwave therapy protocols use 6-12 sessions, but evidence quality varies significantly
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Dr. Amy B Killen · Instagram creator
10.8K views on this video
If you're suffering from erectile dysfunction (or maybe your partner is?) what can you do about it? ! 1) A healthy lifestyle is KEY. What's good for your heart is good for your "man down under" (MDU
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Dr. Amy B Killen, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.